Theophylline Tablet, Extended Release
Product Images NDC 69452-267

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 69452-267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image001 (Image001)

This is a description of Theophylline Extended-Release Tablets, containing 300 mg of theophylline. The tablets are manufactured by Bionpharma and are only available with a prescription. The recommended dosage can be found in the package insert. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). They should be dispensed in a tightly closed container with a child-resistant closure. The tablets are distributed by Bionpharma Inc. in Princeton, NJ and are made in India. There is additional information about an unvarnished area and a 2D code.*

FDA Label Image

Structure (Structutre0001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.